Revenue Highly Dependent on the GLP-1 Track: How Does Lilly Balance Growth and Risk? Feb 9, 2026 Life Science
Biogen’s Financial Report and Outlook Exceed Expectations, Stock Soars Nearly 9% on Friday Feb 6, 2026 Life Science
Amazon Begins Selling Oral Weight-Loss Drug Wegovy, Intensifying Competition in the GLP-1 Retail Market Feb 5, 2026 Life Science
Weight Loss Drug Giant Eli Lilly’s Market Cap Surges Nearly $100 Billion, Accelerating Expansion into New Gene Therapy Sector Feb 4, 2026 Life Science
Johnson & Johnson’s Annual Sales May Break the $100 Billion Mark for the First Time Jan 30, 2026 Life Science
Oral Weight-Loss Drug Wegovy Makes a Strong Debut, Signaling a Turnaround for Novo Nordisk’s Stock? Jan 30, 2026 Life Science
Stop Focusing Solely on AI! This Biotech Dark Horse Is Solving Medical Challenges Where AI Falls Short Jan 29, 2026 Life Science
Don’t Panic If You Missed Eli Lilly, This Biotech Stock Could Be the Next Dark Horse Jan 28, 2026 Life Science
From Weight Loss Drugs to Cancer Vaccines: A Contrarian Bet on Two Biotech Stocks Jan 27, 2026 Life Science
Novo Nordisk Regains Spotlight with New Oral Formulation, Stock May Have 40% Upside Potential Jan 26, 2026 Life Science
Prospects for a Strong Rebound by Two Healthcare Giants: Zoetis and Regeneron Pharmaceuticals Jan 22, 2026 Life Science
